Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • fpbarthel
    Junior Member
    • Dec 2014
    • 5

    #1

    log fold change from glm/poisson

    Hi,

    I'm wondering how to derive the log fold change from the output of R's glm using poisson family (for RNA-seq data). From R's lm function for linear models (for log2 microarray data) the log fold looks like it is the coefficient (beta), but it looks like the glm output needs some transformation to obtain log fold change. Anyone can walk me through the commands to do this?

    Thanks!
  • dariober
    Senior Member
    • May 2010
    • 311

    #2
    Originally posted by fpbarthel View Post
    Hi,

    I'm wondering how to derive the log fold change from the output of R's glm using poisson family (for RNA-seq data).
    Hi- The coefficients from glm with Poisson family distribution by R default are presented as natural log since the link function is log. so you have to anti-log the coefficient by exponentiation to get fold change. E.g.:

    y<- rep(c(10, 40), each= 5)
    x<- rep(c('A', 'B'), each= 5)
    (fit<- glm(y ~ x, family= poisson()))

    Call: glm(formula = y ~ x, family = poisson())

    Coefficients:
    (Intercept) xB
    2.303 1.386

    Degrees of Freedom: 9 Total (i.e. Null); 8 Residual
    Null Deviance: 96.37
    Residual Deviance: -3.997e-14 AIC: 52.44


    fc<- exp(fit$coefficients[2]) ## Antilog coef #2
    log2(fc) ## Convert to more familiar log2 fold change:
    2

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
      by SEQadmin2



      CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

      Despite this, “CRISPR helped turn genome editing from a specialized technique into
      ...
      07-31-2026, 11:01 AM
    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Today, 07:41 AM
    0 responses
    9 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 08-03-2026, 10:13 AM
    0 responses
    24 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-31-2026, 02:55 AM
    0 responses
    38 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-24-2026, 12:17 PM
    0 responses
    25 views
    0 reactions
    Last Post SEQadmin2  
    Working...